Correction to: Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane Oxygenation

Clin Pharmacokinet. 2023 Feb;62(2):349. doi: 10.1007/s40262-023-01218-6.

Pierre Bourgoin^{1

2}, Jules Lecomte³, Mehdi Oualha⁴, Lionel Berthomieu⁵, Tony Pereira⁶, Emeline Davril⁶, Fabien Lamoureux^{6

7}, Nicolas Joram⁸, Alexis Chenouard⁸, Thomas Duflot^{6

7

9}

¹ Pediatric Intensive Care Unit, CHU Nantes, 44093, Nantes, France. pierre.bourgoin@chu-nantes.fr.
² Department of Anesthesiology, CHU Nantes, 44093, Nantes, France. pierre.bourgoin@chu-nantes.fr.
³ Department of Anesthesiology, CHU Nantes, 44093, Nantes, France.
⁴ Pediatric Intensive Care Unit, CHU Necker Enfants Malades, 75015, Paris, France.
⁵ Pediatric Intensive Care Unit, CHU Toulouse, 31059, Toulouse, France.
⁶ INSERM U1096, UNIROUEN, Normandie University, 76000, Rouen, France.
⁷ Department of Pharmacology, CHU Rouen, 76000, Rouen, France.
⁸ Pediatric Intensive Care Unit, CHU Nantes, 44093, Nantes, France.
⁹ CHU Rouen, CIC-CRB U1404, 76000, Rouen, France.

No abstract available

Publication types